March 18, 2021
Published by Adelle McGourty at March 18, 2021
Categories

DS Biopharma and Nuvothera Enter Option and License Agreement for EPADILIN®

• Nuvothera acquires option to licence rights to develop and commercialise DS Biopharma’s EPADILIN® in the US • DS Biopharma becomes an investor in Nuvothera and […]
Do you like it?0
0 Read more